Intuitive Surgical (NASDAQ:ISRG) Given New $513.00 Price Target at BTIG Research

Intuitive Surgical logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • BTIG Research raised its price target on Intuitive Surgical from $454 to $513 and maintained a Buy rating, implying 19.16% upside from the current price.
  • Analyst sentiment is broadly positive: MarketBeat reports a Moderate Buy consensus and an average price target of $495.90.
  • In its latest quarter, Intuitive Surgical beat estimates with EPS of $3.00 versus $2.65 expected and revenue of $3.05 billion versus $2.91 billion; revenue grew 21.7% year over year.
  • MarketBeat previews the top five stocks to own by December 1st.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) had its price objective hoisted by equities research analysts at BTIG Research from $454.00 to $513.00 in a report issued on Wednesday, Benzinga reports. The firm currently has a "buy" rating on the medical equipment provider's stock. BTIG Research's target price would indicate a potential upside of 19.16% from the company's current price.

A number of other analysts also recently issued reports on ISRG. HSBC downgraded shares of Intuitive Surgical from a "buy" rating to a "hold" rating and set a $391.00 price target for the company. in a report on Thursday, July 30th. JPMorgan Chase & Co. increased their price objective on Intuitive Surgical from $450.00 to $475.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 21st. Zacks Research upgraded Intuitive Surgical from a "hold" rating to a "strong-buy" rating in a research report on Thursday, October 22nd. Wells Fargo & Company reissued an "overweight" rating and set a $486.00 target price (down from $487.00) on shares of Intuitive Surgical in a research note on Wednesday, October 21st. Finally, UBS Group restated a "buy" rating on shares of Intuitive Surgical in a research report on Tuesday, October 13th. One research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $495.90.

View Our Latest Report on ISRG

Intuitive Surgical Trading Down 1.6%

Shares of ISRG opened at $430.53 on Wednesday. Intuitive Surgical has a 12-month low of $328.57 and a 12-month high of $603.88. The firm has a 50-day moving average price of $420.62 and a 200 day moving average price of $429.17. The firm has a market capitalization of $149.24 billion, a P/E ratio of 52.06, a P/E/G ratio of 3.02 and a beta of 1.45.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The firm had revenue of $3.05 billion during the quarter, compared to analysts' expectations of $2.91 billion. During the same period last year, the business earned $2.40 earnings per share. Intuitive Surgical's revenue was up 21.7% compared to the same quarter last year. Equities research analysts predict that Intuitive Surgical will post 9.37 earnings per share for the current fiscal year.

Insider Transactions at Intuitive Surgical

In related news, Director Craig Barratt sold 1,150 shares of the stock in a transaction that occurred on Wednesday, November 4th. The shares were sold at an average price of $460.00, for a total transaction of $529,000.00. Following the completion of the transaction, the director owned 1,150 shares of the company's stock, valued at approximately $529,000. This trade represents a 50.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 4,047 shares of the stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $453.21, for a total transaction of $1,834,140.87. Following the transaction, the vice president directly owned 1,026 shares of the company's stock, valued at $464,993.46. The trade was a 79.78% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 39,302 shares of company stock worth $17,708,685. 0.60% of the stock is owned by company insiders.

Institutional Investors Weigh In On Intuitive Surgical

Several institutional investors and hedge funds have recently modified their holdings of ISRG. Bank of America Corp DE grew its holdings in shares of Intuitive Surgical by 3.3% during the 1st quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider's stock valued at $1,667,388,000 after acquiring an additional 116,292 shares in the last quarter. Bank of New York Mellon Corp acquired a new position in shares of Intuitive Surgical in the second quarter worth $1,335,753,000. Amundi raised its holdings in shares of Intuitive Surgical by 8.6% during the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider's stock worth $1,119,448,000 after acquiring an additional 193,096 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its holdings in shares of Intuitive Surgical by 95.3% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider's stock worth $970,635,000 after acquiring an additional 1,027,475 shares in the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. boosted its position in Intuitive Surgical by 10.8% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,893,485 shares of the medical equipment provider's stock valued at $769,948,000 after purchasing an additional 184,044 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

About Intuitive Surgical

(Get Free Report)

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.

Featured Stories

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Intuitive Surgical Right Now?

Before you consider Intuitive Surgical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.

While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines